Cingulate CING
NASDAQ CING
$4.65 +0.12 (+2.74%)
As of: Oct 21, 2026 · 2:20 PM EDT

Cingulate (CING) Revenue (2024 - 2026)

Updated

Analysis

Cingulate (CING) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn 16.99 Bn
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 15.03 Bn
10 Cingulate 61.36 Mn 6.37 Mn - -141,276.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141,276.00
Jun 30, 2025 -138,761.00
Mar 31, 2025 -96,784.00
Jun 30, 2024 -3,497.00
Mar 31, 2024 -24,260.00
API Access

Cingulate Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CING&period=max&api_key=YOUR_API_KEY